Literature DB >> 29654212

Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4+ T Cells in Patients With Type 1 Diabetes.

Meghan L Marre1, John W McGinty2, I-Ting Chow2, Megan E DeNicola3, Noah W Beck1, Sally C Kent3, Alvin C Powers4,5, Rita Bottino6,7, David M Harlan3, Carla J Greenbaum2,8, William W Kwok2,8, Jon D Piganelli1, Eddie A James9.   

Abstract

In spite of tolerance mechanisms, some individuals develop T-cell-mediated autoimmunity. Posttranslational modifications that increase the affinity of epitope presentation and/or recognition represent one means through which self-tolerance mechanisms can be circumvented. We investigated T-cell recognition of peptides that correspond to modified β-cell antigens in subjects with type 1 diabetes. Modified peptides elicited enhanced proliferation by autoreactive T-cell clones. Endoplasmic reticulum (ER) stress in insulinoma cells increased cytosolic calcium and the activity of tissue transglutaminase 2 (tTG2). Furthermore, stressed human islets and insulinomas elicited effector responses from T cells specific for modified peptides, suggesting that ER stress-derived tTG2 activity generated deamidated neoepitopes that autoreactive T cells recognized. Patients with type 1 diabetes had large numbers of T cells specific for these epitopes in their peripheral blood. T cells with these specificities were also isolated from the pancreatic draining lymph nodes of cadaveric donors with established diabetes. Together, these results suggest that self-antigens are enzymatically modified in β-cells during ER stress, giving rise to modified epitopes that could serve to initiate autoimmunity or to further broaden the antigenic repertoire, activating potentially pathogenic CD4+ T cells that may not be effectively eliminated by negative selection.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29654212      PMCID: PMC6014552          DOI: 10.2337/db17-1166

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  48 in total

1.  Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.

Authors:  Suchitra Prasad; Adam P Kohm; Jeffrey S McMahon; Xunrong Luo; Stephen D Miller
Journal:  J Autoimmun       Date:  2012-05-28       Impact factor: 7.094

2.  Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetes.

Authors:  Junbao Yang; I-Ting Chow; Tomasz Sosinowski; Nadia Torres-Chinn; Carla J Greenbaum; Eddie A James; John W Kappler; Howard W Davidson; William W Kwok
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

Review 3.  The endoplasmic reticulum stress response in the pancreatic β-cell.

Authors:  A Volchuk; D Ron
Journal:  Diabetes Obes Metab       Date:  2010-10       Impact factor: 6.577

4.  Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).

Authors:  A Godkin; T Friede; M Davenport; S Stevanovic; A Willis; D Jewell; A Hill; H G Rammensee
Journal:  Int Immunol       Date:  1997-06       Impact factor: 4.823

Review 5.  Endoplasmic reticulum stress and diabetes mellitus.

Authors:  Eiichi Araki; Seiichi Oyadomari; Masataka Mori
Journal:  Intern Med       Date:  2003-01       Impact factor: 1.271

Review 6.  Type 1 diabetes as a relapsing-remitting disease?

Authors:  Matthias von Herrath; Srinath Sanda; Kevan Herold
Journal:  Nat Rev Immunol       Date:  2007-12       Impact factor: 53.106

Review 7.  The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes.

Authors:  Donalyn Scheuner; Randal J Kaufman
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

Review 8.  Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.

Authors:  T P Di Lorenzo; M Peakman; B O Roep
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

Review 9.  β cell ER stress and the implications for immunogenicity in type 1 diabetes.

Authors:  Meghan L Marré; Eddie A James; Jon D Piganelli
Journal:  Front Cell Dev Biol       Date:  2015-10-27

10.  Recognition of posttranslationally modified GAD65 epitopes in subjects with type 1 diabetes.

Authors:  John W McGinty; I-Ting Chow; Carla Greenbaum; Jared Odegard; William W Kwok; Eddie A James
Journal:  Diabetes       Date:  2014-04-04       Impact factor: 9.461

View more
  33 in total

1.  T-cell responses to hybrid insulin peptides prior to type 1 diabetes development.

Authors:  Angela M Mitchell; Aimon A Alkanani; Kristen A McDaniel; Laura Pyle; Kathleen Waugh; Andrea K Steck; Maki Nakayama; Liping Yu; Peter A Gottlieb; Marian J Rewers; Aaron W Michels
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

2.  The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes.

Authors:  Ernesto S Nakayasu; Wei-Jun Qian; Carmella Evans-Molina; Raghavendra G Mirmira; Decio L Eizirik; Thomas O Metz
Journal:  Expert Rev Proteomics       Date:  2019-06-24       Impact factor: 3.940

Review 3.  Neoepitopes: a new take on beta cell autoimmunity in type 1 diabetes.

Authors:  Stuart I Mannering; Anthony R Di Carluccio; Colleen M Elso
Journal:  Diabetologia       Date:  2018-11-06       Impact factor: 10.122

4.  Protecting functional β cells with a therapeutic peptide.

Authors:  Meghan L Marré; Jon D Piganelli; Eddie A James
Journal:  Ann Transl Med       Date:  2018-09

5.  Identification of Human Antigen-Specific CD4+ Cells with Peptide-MHC Multimer Technologies.

Authors:  I-Ting Chow; William W Kwok
Journal:  Methods Mol Biol       Date:  2021

6.  The Endoplasmic Reticulum and Calcium Homeostasis in Pancreatic Beta Cells.

Authors:  Irina X Zhang; Malini Raghavan; Leslie S Satin
Journal:  Endocrinology       Date:  2020-02-01       Impact factor: 4.736

7.  T-Cell Epitopes and Neo-epitopes in Type 1 Diabetes: A Comprehensive Update and Reappraisal.

Authors:  Eddie A James; Roberto Mallone; Sally C Kent; Teresa P DiLorenzo
Journal:  Diabetes       Date:  2020-07       Impact factor: 9.461

Review 8.  Pancreas Pathology During the Natural History of Type 1 Diabetes.

Authors:  Teresa Rodriguez-Calvo; Sarah J Richardson; Alberto Pugliese
Journal:  Curr Diab Rep       Date:  2018-10-06       Impact factor: 4.810

Review 9.  Modeling Type 1 Diabetes Using Pluripotent Stem Cell Technology.

Authors:  Kriti Joshi; Fergus Cameron; Swasti Tiwari; Stuart I Mannering; Andrew G Elefanty; Edouard G Stanley
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-01       Impact factor: 5.555

Review 10.  Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.

Authors:  Mei-Ling Yang; Fernanda M C Sodré; Mark J Mamula; Lut Overbergh
Journal:  Front Immunol       Date:  2021-06-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.